About Us
Direct Biologics is a market leading innovator and science-based cGMP manufacturer of regenerative biologic products. The Company is committed to providing the latest clinical and scientific information through rigorous and thorough research.
With deep knowledge and industry expertise in cellular and regenerative therapies, the company has brought to market a significant development in therapeutic biologics with the introduction of the highest quality production of extracellular vesicles.
Innovation
Direct Biologics was created to expand the science of cutting-edge human cell and tissue technologies through research and has built extensive intellectual property surrounding stem cells and their utility.
Safety
Direct Biologics is committed to patient safety. All regulated processes are compliant with cGxP to ensure the highest safety and quality throughout every stage of our product.
Quality
Direct Biologics provides quality products for healthcare providers and patients. Exceptional quality standards are maintained by continuous improvement of the quality system to provide safe and consistent products.
Our Team
Direct Biologics’ management team holds extensive collective experience in biologics research, development, and commercialization, making the Company a leader in the evolving, next generation segment of the biotherapeutics industry.
Mark Adams
Co-Founder & Chief Executive Officer
John Vacalis
President and Chief Legal Officer
Paul Tebbey
Chief Operating Officer
Jeff Mims
Chief Financial Officer
Bruce Middleton
Senior Vice President, Operations
Travis Frick
Vice President, Manufacturing
John Constantine
Director, Investor Relations
Rob Heckler
Vice President, Information Technology Cyber Security
Learn more about Direct Biologics
We welcome your questions and inquiries – contact us today!